Incannex Healthcare (IXHL) Climbs 150% Following Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

Visit StreetInsider.com at http://www.streetinsider.com/Momentum+Movers/Incannex+Healthcare+%28IXHL%29+Climbs+150%25+Following+Positive+Topline+Results+from+Phase+2+Psi-GAD1+Clinical+Trial+of+Psilocybin+in+Generalised+Anxiety+Disorder/22847903.html for the full story.